Arcutis Biotherapeutics, Inc. ARQT Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s shares (diluted)?
- Arcutis Biotherapeutics, Inc. (ARQT) reported shares (diluted) of 129.4M in Q1 2026.
- How has Arcutis Biotherapeutics, Inc.'s shares (diluted) changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s shares (diluted) increased by 2.6% year-over-year, from 126M to 129.4M.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s shares (diluted)?
- Over 4 years (2021 to 2025), Arcutis Biotherapeutics, Inc.'s shares (diluted) has grown at a 27.1% compound annual growth rate (CAGR), from 196.8M to 513.2M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.